- 询价
- R&D
- 美国/中国
- xy-3434
- 2025年07月15日
- 科研使用
- Goat，Rabbit，Mouse
- 人，大鼠，小鼠，兔
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态：
液态/粉状
- 保存条件：
-20℃保存
- 克隆性：
多克隆
- 标记物：
见说明书
- 适应物种：
人，大鼠，小鼠，兔
- 宿主：
Goat，Rabbit，Mouse
- 应用范围：
科研使用
- 浓度：
1mg/1ml
- 靶点：
来电咨询
- Hepatitis C Virus (HCV) Monoclonal Antibody, Purified (SIGNET)详细信息：
-
Description 
Purified Monoclonal Antibody against HCV (Hepatitis C Virus)
(Formerly Signet Catalog Nos: 434-01, 434-26 L2 Predilute)Intended Use **Research Use Only (RUO)**
This product is sold for laboratory research use only, not for human or in-vivo use.Clone Tordji-22 Form Purified Antibody (in 0.01M PBS + 0.1% NaN3 + 1% BSA) Host Hepatitis C Virus (HCV) Monoclonal Antibody, Purified (SIGNET)Mouse IsoType IgG1 Specificity The Signet anti-Hepatitis C Virus (HCV) monoclonal antibody reacts specifically with hepatitis C virus. TORDJI-22 is specific for the non-structural region of HCV (NS3-NS4). A granular staining pattern is observed in the cytoplasm of infected cells. No cross-reactivity with hepatitis B surface antigen or hepatitis A has been detected. This antibody was developed using a synthetic peptide of the hepatitis C non-structural gene sequence.
Concentrated Format:
SIG-3462-1000 [1 mL]
Prediluted Formats:
SIG-3462-26 [6 mL] is ready-to-use with Biotin-based detection systems such as Signets USA Ultrastreptavidin Detection (SIG-32250).Uses Hepatitis C Virus (HCV) Monoclonal Antibody, Purified (SIGNET)This antibody is effective in immunohistochemistry (IHC). Suggested Working Dilution The optimal working dilution should be determined for each specific assay condition. - IHC: ≥1:40 (concentrated format) with Biotin based detection systems such as Signets USA Ultrastreptavidin Detection (SIG-32250).
Tissue Sections: Formalin-fixed, paraffin-embedded tissues
Pretreatment: Digestion with pepsin for 10 min. at 37°C.
Incubation: 60 minutes at room temperature
Notes Positive tissue (human): HCV-infected liver Storage Store between 2-8°C. Warranty/Conditions Covance products may not be resold or modified for resale without prior written approval. - IHC: ≥1:40 (concentrated format) with Biotin based detection systems such as Signets USA Ultrastreptavidin Detection (SIG-32250).
- Hepatitis C Virus (HCV) Monoclonal Antibody, Purified (SIGNET)
- xy-13458R GMIPGEM相互作用蛋白抗体
xy-8581R GSTCD谷胱甘肽硫转移酶C段结构域抗体
xy-8582R GTDC1糖基转移酶样1抗体
xy-9205R GDE3促进成骨细胞分化因子抗体
xy-9206R GDPD3甘油磷酸二酯酶磷酸结构域3抗体
xy-13346R GGCTγ-谷氨酰基环转移酶抗体
xy-1288G GDF8生长分化因子8/肌肉抑制素抗体
xy-4499R VP3 Goose parvovirus鹅细小病毒GPV抗体
xy-1189R Gastrin胃泌素/蛙皮素抗体
xy-0459R GAPDH3-磷酸甘油醛脱氢酶（兔来源免疫组化用抗体）
xy-1024R GDNF胶质细胞源性神经营养因子抗体
xy-4631R Beta galactosidaseβ半乳糖苷酶抗体
xy-0533R GABABR1gamma氨基丁酸B型受体1抗体
xy-0348R G protein beta subunit GIG蛋白/鸟苷酸结合蛋白抗体
xy-0168R GFRA4GDNF家族受体α4抗体 GDNFRα4
xy-0017M Galanin神经节肽抗体
xy-6832R Glutaredoxin 1谷氧还蛋白/巯基转移酶抗体
xy-15375R GPR113G蛋白偶联受体GPR113蛋白抗体
xy-9927R GALR1甘丙肽受体1抗体
xy-1776R GADD34生长抑制DNA损伤基因34抗体
xy-1794R GDF1生长分化因子1抗体
xy-1796R GLK葡萄糖激酶抗体
xy-1807R GPR78G蛋白偶联受体78抗体
xy-3515R GIG8DNA结合抑制因子2抗体
xy-1793R GCP2粒细胞趋化蛋白2抗体
xy-1779R GATA5GATA结合蛋白5抗体
xy-1795R GDF9生长分化因子9抗体
xy-1894R GRM4促代谢型谷氨酸受体4抗体
xy-2122R GST tagGST标签蛋白抗体
xy-2159R Glypican 4磷脂酰基醇蛋白聚糖-4抗体
xy-0617R Cobra poison Protein眼镜蛇蛇毒蛋白抗体
xy-11018R GALNT14GalNAc-T14抗体
xy-12592R GREM2骨形态形成蛋白拮抗蛋白2抗体
xy-15587R GPAT4甘油酰基转移酶4抗体
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Hepatic carcinogenesis is a complex process that involves profound alterations of the hepatocyte genome (1,2) and has been graded in three stages: induction, promotion, and progression in the animal models (3–5). In recent years, the use
Production of Human Monoclonal Antibodies to Hepatitis C Virus and Their Characterization
Human monoclonal antibodies (hMAb) provide novel ways to probe the B-cell repertoire in health and disease. However, the development of hMAb technology has met with several difficulties owing to the instability of the cell lines, the low
Nomenclature and Numbering of the Hepatitis C Virus
International standardization and coordination of the nomenclature of variants of hepatitis C virus (HCV) is increasingly needed as more is discovered about the scale of HCV-related liver disease and important biological and antigenic
技术资料暂无技术资料 索取技术资料
